When should I stop using Tretinoin (all-trans retinoic acid) before becoming pregnant?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

When to Stop Tretinoin Before Pregnancy

Women should stop using tretinoin (all-trans retinoic acid) at least 1 month before attempting to conceive to minimize any potential risk to the developing fetus.

Understanding Tretinoin and Pregnancy Concerns

Tretinoin is a topical retinoid that requires special consideration when planning pregnancy due to its similarity to other retinoids that are known teratogens. While the evidence for topical tretinoin specifically is somewhat reassuring, caution is warranted.

Key Considerations:

  • Systemic vs. Topical Absorption: Topical tretinoin has much lower systemic absorption compared to oral retinoids like isotretinoin or acitretin
  • Half-life: Tretinoin has a relatively short half-life compared to oral retinoids
  • Timing: The most critical period for potential teratogenicity is during early embryonic development (3-6 weeks of gestation)

Guidelines for Discontinuation

The timing recommendations for discontinuing tretinoin differ from those for oral retinoids:

  • Topical tretinoin: Discontinue at least 1 month before attempting conception 1
  • Oral isotretinoin: Requires waiting at least 1 month after discontinuation 2
  • Oral acitretin: Requires waiting 3 years after discontinuation due to its conversion to etretinate, which has a very long half-life (168 days) 3

Evidence on Topical Tretinoin Safety

Several studies have examined the safety of topical tretinoin during pregnancy:

  • A prospective study of 106 women with first-trimester exposure to topical tretinoin found no increased risk of spontaneous abortion, major structural defects, or retinoic acid-specific minor malformations compared to unexposed women 4

  • Another study of 215 women exposed to topical tretinoin in early pregnancy found no increased risk of major congenital anomalies (relative risk 0.7,95% CI 0.2-2.3) 5

Important Distinctions Between Retinoids

It's crucial to distinguish between different retinoid preparations:

  1. Topical tretinoin (Retin-A): Has minimal systemic absorption and shorter half-life

    • Recommended discontinuation: 1 month before conception
  2. Oral isotretinoin (Accutane): Known human teratogen with high systemic levels

    • Recommended discontinuation: At least 1 month before conception
  3. Oral acitretin: Can convert to etretinate with extremely long half-life

    • Recommended discontinuation: 3 years before conception 3

Recommendations for Women Planning Pregnancy

  1. Stop topical tretinoin at least 1 month before attempting conception
  2. Use effective contraception until discontinuation of tretinoin
  3. Consider alternative acne treatments that are pregnancy-safe if needed
  4. Consult with a dermatologist and obstetrician for personalized advice

Special Considerations

  • If accidental exposure occurs during pregnancy, the risk appears to be relatively low for topical tretinoin specifically 4, 5
  • Women who become pregnant while using topical tretinoin should discuss their individual risk with their healthcare provider
  • The timing of conception relative to tretinoin discontinuation can help assess potential risk 6

While the evidence suggests topical tretinoin may pose minimal risk, the safest approach is to discontinue use at least 1 month before attempting conception to eliminate any potential concern during this important time.

References

Research

Safety of skin care products during pregnancy.

Canadian family physician Medecin de famille canadien, 2011

Guideline

Isotretinoin Use and Pregnancy Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Pregnancy after isotretinoin use].

Nederlands tijdschrift voor geneeskunde, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.